The GLP-1 receptor agonist class includes several medications: Semaglutide (brand names Wegovy for weight loss, Ozempic for diabetes) Liraglutide (brand names Saxenda for weight loss, Victoza for diabetes) Tirzepatide (brand name Zepbound for weight loss, Mounjaro for diabetes), which is technically a dual GIP/GLP-1 receptor agonist Dulaglutide (Trulicity, for diabetes) Tirzepatide deserves special mention because it targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
It means alcohol works against your goal through several mechanisms at once, and the effect adds up over weeks
The GIP component adds another layer
Supportive policies not only expand access but also help reduce stigma around virtual care, making it easier for patients to seek treatment with confidence
PMCID: PMC12502165
SGLT2 inhibitors, another class of diabetes drug, went generic in India six years ago and still havent made it to government clinics